300 Prevalence and characteristics of attention deficit hyperactivity disorder (ADHD) in patients with cystic fibrosis (CF)

Patients with Cystic fibrosis (CF) need daily treatments to control the disease, which requires time, energy, and persistence. One possible barrier to adherence may be co-morbidity with Attention deficit hyperactivity disorder (ADHD), which has a prevalence of 7% in the general population. ADHD is associated with functional impairment in multiple settings including self-care. Increased inflammatory marker levels were detected in ADHD-patients suggesting a probable association with chronic inflammatory illnesses. It is believed that patients who suffer from comorbid ADHD symptomatology “on top” of chronic diseases may experience greater difficulty in controlling their primary disease. Few studies have analyzed the influence of ADHD in CF patients.